UNSPSC 51361809: Dexmedetomidine hydrochloride

This classification denotes an alpha-adrenergic agonist with the molecular formula C13H16N2.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1018WH7F9I, chemically known as 1h-imidazole, 4-(1-(2,3-dimethylphenyl)ethyl)-, monohydrochloride, (+-)- but more generally known as dexmedetomidine hydrochloride, which bears US NIH Compound Identifier 68601. European Medicines Agency schedules Dexmedetomidine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB20317.

UNSPSC 51361809 Dexmedetomidine hydrochloride is a Commodity code. State and local governments procure this pharmaceutical agent—a sedative and analgesic used in emergency medical, law enforcement, and community health settings—through competitive bidding processes. Recent solicitations show demand for this product paired with related emergency-response supplies and drug-management systems, typically as part of broader public-health initiatives rather than standalone pharmaceutical orders. Issuing bodies include county health departments and community health divisions pursuing opioid-response and emergency-preparedness programs.

Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford. The bid deadline was July 26, 2023, and the contract carried a two-year initial term with a one-year renewal option, subject to a three-month probationary period. Vendors were required to submit unit costs, maintain workers' compensation and general liability insurance, comply with E-Verify eligibility confirmation, and meet federal compliance requirements including Clean Air Act and Federal Water Pollution Control Act standards, with potential FEMA funding driving additional federal-level accountability and audit protocols. The source shows limited recent activity under this code—a single opportunity from a Florida county health procurement office—leaving the geographic spread and issuing-body concentration unclear from current data.